Euglena Balance Sheet Health
Financial Health criteria checks 4/6
Euglena has a total shareholder equity of ¥30.8B and total debt of ¥26.2B, which brings its debt-to-equity ratio to 85.2%. Its total assets and total liabilities are ¥71.6B and ¥40.8B respectively.
Key information
85.2%
Debt to equity ratio
JP¥26.19b
Debt
Interest coverage ratio | n/a |
Cash | JP¥19.81b |
Equity | JP¥30.75b |
Total liabilities | JP¥40.84b |
Total assets | JP¥71.59b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 2931's short term assets (¥29.4B) exceed its short term liabilities (¥12.2B).
Long Term Liabilities: 2931's short term assets (¥29.4B) exceed its long term liabilities (¥28.7B).
Debt to Equity History and Analysis
Debt Level: 2931's net debt to equity ratio (20.8%) is considered satisfactory.
Reducing Debt: 2931's debt to equity ratio has increased from 33.8% to 85.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 2931 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 2931 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.